A carregar...

Intraprostatic Botulinum Toxin injection in patients with benign prostatic enlargement

Histological evidence of benign prostatic hyperplasia (BPH) exceeded 50% in men over 50 years of age and rose to 75% as men entered the eighth decade. Therapeutic options for BPH generally fall into one of the three categories: watchful waiting, medical treatment and surgery. Excluding watchful wait...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ilie, CP, Chancellor, MB, Chuang, YC, Mischianu, D
Formato: Artigo
Idioma:Inglês
Publicado em: Carol Davila University Press 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3019017/
https://ncbi.nlm.nih.gov/pubmed/20108746
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!